Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Montgomery, Ala.-based Jackson Hospital has named Medline as its primary supplier for environmental services products. The partnership builds on their existing relationship, as Medline has been Jackson Hospital's medical surgical prime vendor for over nine years.
A new study revealed that reports of drug-related supply chain issues are 40% less likely to result in shortages in Canada than in the U.S.
Baxter restarted its highest-throughput IV solutions manufacturing line, which accounts for approximately 25% of the site's total production and approximately 50% of 1-liter IV solutions, the most commonly used size by hospitals and clinics, according to an Oct. 31 news…
Exactech, a Gainesville, Fla.-based medical device maker, filed for Chapter 11 bankruptcy on Oct. 29 and has entered a restructuring agreement to sell its assets to a group of existing investors.
Angola, Ind.-based Cameron Memorial Community Hospital recently joined the Vanderbilt Health Purchasing Collaborative, according to an Oct. 30 LinkedIn post from the program.
Hacking remains cause nearly 80% data breaches in healthcare, according to a new report from Forescout Technologies, a cybersecurity company.
Baxter has received FDA approval to extend the shelf life of more than 50 intravenous and irrigation products by up to 12 months, now allowing for a 24-month expiry from products made before September 2024, according to an Oct. 28…
Medical technology company Olympus has dismissed CEO Stefan Kaufmann in the wake of an allegation that he bought illegal drugs.
The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable embolic device.
Three months after Jeff Shuren, MD, announced his retirement as the FDA's director of the Center for Devices and Radiological Health, the agency tapped Michelle Tarver, MD, PhD, to fill the role.